It is considered a promising biomarker as increased expression of Cathepsin B was reported in various types of metastasis and invasive cancers such as lung, breast, ovary, colon, gastric, nasopharyngeal and oral cancer [23]. This evidence concerns the gene CTSB and lip and oral cavity carcinoma.